DK0495910T3 - Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer - Google Patents

Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer

Info

Publication number
DK0495910T3
DK0495910T3 DK90916421T DK90916421T DK0495910T3 DK 0495910 T3 DK0495910 T3 DK 0495910T3 DK 90916421 T DK90916421 T DK 90916421T DK 90916421 T DK90916421 T DK 90916421T DK 0495910 T3 DK0495910 T3 DK 0495910T3
Authority
DK
Denmark
Prior art keywords
human
protein
preparation
directed antibodies
antibodies
Prior art date
Application number
DK90916421T
Other languages
Danish (da)
English (en)
Inventor
Lance A Liotta
Charles R King
Patricia S Steeg
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0495910T3 publication Critical patent/DK0495910T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK90916421T 1989-10-18 1990-10-17 Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer DK0495910T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42280189A 1989-10-18 1989-10-18
PCT/US1990/005849 WO1991005793A1 (en) 1989-10-18 1990-10-17 Production and use of human nm23 protein and antibodies therefor

Publications (1)

Publication Number Publication Date
DK0495910T3 true DK0495910T3 (da) 2002-01-14

Family

ID=23676440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90916421T DK0495910T3 (da) 1989-10-18 1990-10-17 Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer

Country Status (10)

Country Link
US (3) US6423836B1 (es)
EP (1) EP0495910B1 (es)
JP (2) JP2758500B2 (es)
AT (1) ATE206129T1 (es)
AU (1) AU643971B2 (es)
CA (1) CA2067797C (es)
DE (1) DE69033810T2 (es)
DK (1) DK0495910T3 (es)
ES (1) ES2164634T3 (es)
WO (1) WO1991005793A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770386A (en) * 1992-05-20 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
WO1998044088A2 (en) * 1997-04-03 1998-10-08 Joslin Diabetes Center, Inc. Modulating the rad-nm23 interaction
US20020197253A1 (en) * 2001-05-22 2002-12-26 Cheek Dennis J. Compositions and methods for promoting or inhibiting NDPK
GB0124145D0 (en) * 2001-10-08 2001-11-28 Bayer Ag Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
CN101918556B (zh) * 2007-09-04 2013-06-12 株式会社普罗赛尔制药 可穿透细胞的nm23重组蛋白、编码其的多核苷酸以及包含其的抗转移组合物
EP2707021B1 (en) * 2011-05-09 2024-02-21 Minerva Biotechnologies Corporation Genetically engineered growth factor variants

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35097A (en) * 1862-04-29 Improvement in machines for upsetting tires
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4808528A (en) * 1983-05-19 1989-02-28 Karl Tryggvason Antibody composition for the detection of malignant cells with metastatic cell activity
US4816400A (en) * 1983-05-19 1989-03-28 Karl Tryggvason Basement membrane collagen degrading enzyme and method of purifying same
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
WO1986003226A1 (en) * 1984-11-30 1986-06-05 Whitehead Institute For Biomedical Research Transmissible, mammalian genes associated with tumor metastasis
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
JPH01156999A (ja) * 1988-09-03 1989-06-20 Dainippon Pharmaceut Co Ltd ヒト癌壊死因子
WO1991006671A1 (fr) * 1989-10-31 1991-05-16 Institut Pasteur Moyens pour la detection de cellules hautement proliferatives
FR2653781B1 (fr) * 1989-10-31 1992-02-07 Pasteur Institut Procede de synthese de derives d'adenosine phosphate et derives obtenus.
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein

Also Published As

Publication number Publication date
CA2067797A1 (en) 1991-04-19
JP3295358B2 (ja) 2002-06-24
US6087117A (en) 2000-07-11
DE69033810D1 (de) 2001-10-31
US6329198B1 (en) 2001-12-11
ATE206129T1 (de) 2001-10-15
EP0495910A1 (en) 1992-07-29
CA2067797C (en) 1997-03-04
US6423836B1 (en) 2002-07-23
ES2164634T3 (es) 2002-03-01
JPH10212299A (ja) 1998-08-11
DE69033810T2 (de) 2002-03-28
AU643971B2 (en) 1993-12-02
EP0495910A4 (en) 1993-09-15
WO1991005793A1 (en) 1991-05-02
AU7042491A (en) 1991-05-16
JP2758500B2 (ja) 1998-05-28
JPH04506457A (ja) 1992-11-12
EP0495910B1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
DK0972201T3 (da) Forbindelser til immundiagnosticering af prostatacancer og fremgangsmåder til anvendelse heraf
SG46455A1 (en) Intraoperative and endoscopic tumor detection and therapy
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
ATE299180T1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
ATE303161T1 (de) Humanisierung von anti-carcinoembryonalen antigen anti-idiotypischen antikörper und dessen verwendung als tumorvakzin und zur markierung
IS6322A (is) Viðtaki APRIL (BCMA) og notkun hans
PT935607E (pt) Proteinas de fusao de classe ii do cph soluveis monovalentes e multivalentes, e suas utilizacoes
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
DE69519796D1 (de) PTPalpha-Bestimmung in der Tumordiagnose und -Prognose
DE69128543D1 (de) Monoklonale antikörper der maus
ATE315231T1 (de) Verfahren zur feststellung der anwesenheit mutierten brca proteins
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
DE68921979D1 (de) Antikörper für die antilymphozyten-antikörpertherapie.
FI913391A0 (fi) Foerfarande foer detektering av smaocellcarcinom och anvaendning av acylpeptidhydrolas och denna kodande sekvenser.
ES2142070T3 (es) Utilizacion de un complejo ficobiliproteina-peptido de enlace como trazador fluorescente.
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
ATE265533T1 (de) Saeugetierchemokine
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
ES8802196A1 (es) Metodo para determinar la presion de un estado maligno en tejidos.
BR9911294A (pt) Composição para o tratamento de imuno deficiências e métodos para sua preparação e uso
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
ATE295874T1 (de) Differenzierungsfaktor der hypophyse und methoden zu seiner verwendung.